MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

11-Ketodihydrotestosterone

CAS No. : 32694-37-4

MCE 站：11-Ketodihydrotestosterone

产品活性：11-Ketodihydrotestosterone (11-KDHT; 5α-Dihydro-11-keto testosterone) 是一种内源性类固醇，是 11β-羟基雄烯二酮的代谢产物。11-Ketodihydrotestosterone 是一种活性雄激素，也是一种有效的雄激素受体 (AR) 激动剂，对人 AR 的 K_i 为 20.4 nM，EC₅₀ 为 1.35 nM。11-Ketodihydrotestosterone 在雄激素依赖性前列腺癌细胞中诱导基因调节，蛋白质表达和细胞生长。

研究领域：Others

作用靶点：Androgen Receptor

In Vitro: 11-Ketodihydrotestosterone (11-KDHT; 1-10 nM; 24 hours; LNCaP and VCaP cells) treatment induces significant cell proliferation.
11-Ketodihydrotestosterone (11-KDHT; 0.1-10 nM; 7-10 days; LNCaP and VCaP cells) treatment results in the significant upregulation of KLK3, TMPRSS2 and FKBP5 in both LNCaP and VCaP cells, with the exception of KLK3 at 1 nM in LNCaP cells.
In PNT2 cells, only 20% of 11β-hydroxyandrostenedione (11OHA4) and 11β-hydroxytestosterone (11OHT) are metabolised with the former yielding 11keto-androstenedione (11KA4), 11-Ketodihydrotestosterone (11-KDHT) and 11β-hydroxy-5α-androstanedione (11OH-5αDIONE) and the latter yielding 11OHA4, 11KT and 11-Ketodihydrotestosterone with downstream products <0.03 μM.
In prostate cancer tissue, C11-oxy C19 metabolites at significantly higher levels than the C19 steroids are detected, with unconjugated 11-Ketodihydrotestosterone, 11KT and 11OHA4 levels ranging between 13 and 37.5 ng/g. Analyses of total steroid levels in plasma show significant levels of 11OHA4 (≈230-440 nM), 11KT (≈250-390 nM) and 11-Ketodihydrotestosterone (≈19 nM).

相关产品：Enzalutamide  |  DHEA  |  Apalutamide  |  Medroxyprogesterone acetate  |  Bicalutamide  |  Darolutamide  |  Flutamide  |  Danazol  |  Dimethylcurcumin  |  Spironolactone  |  AZD3514  |  BMS-564929  |  LGD-3303  |  RAD140  |  Ailanthone  |  Ostarine  |  UT-155  |  Cyproterone acetate  |  Epiandrosterone  |  3,3´-Diindolylmethane  |  Lupeol  |  Testosterone propionate  |  ACP-105  |  Triptophenolide  |  Boldenone Undecylenate  |  LY2452473  |  MK-0773  |  Nilutamide  |  Andarine

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。